Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1988 1
1992 2
1993 3
1994 3
1995 6
1996 5
1997 9
1998 10
1999 7
2000 17
2001 15
2002 12
2003 9
2004 17
2005 17
2006 20
2007 12
2008 16
2009 7
2010 13
2011 12
2012 21
2013 19
2014 21
2015 19
2016 19
2017 22
2018 25
2019 24
2020 19
2021 20
2022 12
2023 20
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

442 results

Results by year

Filters applied: . Clear all
Page 1
ACG Clinical Guideline: Management of Crohn's Disease in Adults.
Lichtenstein GR, Loftus EV, Isaacs KL, Regueiro MD, Gerson LB, Sands BE. Lichtenstein GR, et al. Am J Gastroenterol. 2018 Apr;113(4):481-517. doi: 10.1038/ajg.2018.27. Epub 2018 Mar 27. Am J Gastroenterol. 2018. PMID: 29610508
Infliximab for induction and maintenance therapy for ulcerative colitis.
Rutgeerts P, Sandborn WJ, Feagan BG, Reinisch W, Olson A, Johanns J, Travers S, Rachmilewitz D, Hanauer SB, Lichtenstein GR, de Villiers WJ, Present D, Sands BE, Colombel JF. Rutgeerts P, et al. Among authors: lichtenstein gr. N Engl J Med. 2005 Dec 8;353(23):2462-76. doi: 10.1056/NEJMoa050516. N Engl J Med. 2005. PMID: 16339095 Free article. Clinical Trial.
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.
Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, Rachmilewitz D, Wolf DC, Olson A, Bao W, Rutgeerts P; ACCENT I Study Group. Hanauer SB, et al. Among authors: lichtenstein gr. Lancet. 2002 May 4;359(9317):1541-9. doi: 10.1016/S0140-6736(02)08512-4. Lancet. 2002. PMID: 12047962 Clinical Trial.
Achalasia.
Lichtenstein GR. Lichtenstein GR. Gastroenterol Hepatol (N Y). 2017 Jul;13(7):388. Gastroenterol Hepatol (N Y). 2017. PMID: 28867967 Free PMC article. No abstract available.
Functional Dyspepsia.
Lichtenstein GR. Lichtenstein GR. Gastroenterol Hepatol (N Y). 2020 Feb;16(2):59. Gastroenterol Hepatol (N Y). 2020. PMID: 34035703 Free PMC article. No abstract available.
Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study.
Peyrin-Biroulet L, Allegretti JR, Rubin DT, Bressler B, Germinaro M, Huang KG, Shipitofsky N, Zhang H, Wilson R, Han C, Feagan BG, Sandborn WJ, Panés J, Hisamatsu T, Lichtenstein GR, Sands BE, Dignass A; QUASAR Study Group. Peyrin-Biroulet L, et al. Among authors: lichtenstein gr. Gastroenterology. 2023 Dec;165(6):1443-1457. doi: 10.1053/j.gastro.2023.08.038. Epub 2023 Sep 1. Gastroenterology. 2023. PMID: 37659673 Free article. Clinical Trial.
Third-Space Endoscopy.
Lichtenstein GR. Lichtenstein GR. Gastroenterol Hepatol (N Y). 2018 Apr;14(4):203. Gastroenterol Hepatol (N Y). 2018. PMID: 29942218 Free PMC article. No abstract available.
Gluten-Free Diet.
Lichtenstein GR. Lichtenstein GR. Gastroenterol Hepatol (N Y). 2018 Feb;14(2):67. Gastroenterol Hepatol (N Y). 2018. PMID: 29606919 Free PMC article. No abstract available.
Medical Foods.
Lichtenstein GR. Lichtenstein GR. Gastroenterol Hepatol (N Y). 2017 Feb;13(2):75. Gastroenterol Hepatol (N Y). 2017. PMID: 28450814 Free PMC article. No abstract available.
442 results